AlzChem Group AG carries a market capitalization of 1.71B, placing it among publicly traded companies globally. Its enterprise value stands at 1.39B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.71B |
| Enterprise Value | 1.39B |
AlzChem Group AG currently has 10.10M shares outstanding.
| Shares Outstanding | 10.10M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
AlzChem Group AG trades at a trailing price-to-earnings ratio of 24.28. The price-to-sales ratio is 2.53, and the price-to-book ratio stands at 4.67.
| PE Ratio | 24.28 |
| PS Ratio | 2.53 |
| PB Ratio | 4.67 |
| P/TBV Ratio | 6.52 |
| P/FCF Ratio | 10.05 |
| P/OCF Ratio | 12.49 |
On an enterprise value basis, AlzChem Group AG trades at an EV/EBITDA multiple of 16.51 and an EV/FCF ratio of 9.67. The EV/Sales ratio of 2.50 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 16.51 provides insight into valuation relative to core operating earnings.
| EV / Sales | 2.50 |
| EV / EBITDA | 16.51 |
| EV / EBIT | 16.51 |
| EV / FCF | 9.67 |
AlzChem Group AG maintains a current ratio of 2.84, meaning it holds 2.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 21.76, indicating elevated leverage, while an interest coverage ratio of 15.12 demonstrates strong ability to service its debt obligations.
| Current Ratio | 2.84 |
| Quick Ratio | 0.61 |
| Debt / Equity | 21.76 |
| Debt / EBITDA | 0.57 |
| Interest Coverage | 15.12 |
AlzChem Group AG posts a return on equity of 20.61 and a return on invested capital of 23.01.
| Return on Equity (ROE) | 20.61 |
| Return on Assets (ROA) | 11.40 |
| Return on Invested Capital (ROIC) | 23.01 |
| Return on Capital Employed (ROCE) | 18.39 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.63 |
Over the trailing twelve months, AlzChem Group AG has paid 22.39M in income taxes, reflecting an effective tax rate of 27.82.
| Income Tax | 22.39M |
| Effective Tax Rate | 27.82 |
AlzChem Group AG's stock has gained approximately 14.32432% over the past 52 weeks. The 50-day moving average sits at 174.23, while the 200-day moving average is 159.85.
| Beta (5Y) | N/A |
| 52-Week Price Change | 14.32432% |
| 50-Day Moving Average | 174.23 |
| 200-Day Moving Average | 159.85 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, AlzChem Group AG generated 555.54M in revenue and converted that into 57.92M in net income, yielding earnings per share of 5.73. EBITDA reached 84.28M, while operating income came in at 84.28M.
| Revenue | 555.54M |
| Gross Profit | 372.66M |
| Operating Income | 84.28M |
| Pretax Income | 80.49M |
| Net Income | 57.92M |
| EBITDA | 84.28M |
| EBIT | 84.28M |
| Earnings Per Share (EPS) | 5.73 |
AlzChem Group AG holds 64.28M in cash and equivalents against 47.72M in total debt, resulting in a net debt position of -20.00M. Total book value stands at 300.84M, with working capital of 193.59M providing operational flexibility.
| Cash & Cash Equivalents | 64.28M |
| Total Debt | 47.72M |
| Net Debt | -20.00M |
| Equity (Book Value) | 300.84M |
| Book Value Per Share | 29.70 |
| Working Capital | 193.59M |
AlzChem Group AG produced 112.56M in operating cash flow over the past twelve months. After subtracting -27.39M in capital expenditures, free cash flow totaled 85.16M - equivalent to 8.41 per share.
| Operating Cash Flow | 112.56M |
| Capital Expenditures | -27.39M |
| Free Cash Flow | 85.16M |
| FCF Per Share | 8.41 |
AlzChem Group AG operates with a gross margin of 67.08, reflecting its pricing power and cost economics. The operating margin of 15.17 and net profit margin of 10.43 provide insight into operational efficiency.
| Gross Margin | 67.08 |
| Operating Margin | 15.17 |
| Pretax Margin | 14.49 |
| Profit Margin | 10.43 |
| EBITDA Margin | 15.17 |
The company's payout ratio of 31.22 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 1.80 |
| Dividend Yield | N/A |
| Payout Ratio | 31.22 |
| Shareholder Yield | 2.47 |
| FCF Yield | 9.95 |
AlzChem Group AG's most recent stock split took place on July 1, 2019 with a 10:1 split ratio.
| Last Split Date | 7/1/2019 |
| Split Ratio | 10:1 |
AlzChem Group AG posts an Altman Z-Score of 4.98, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 4.98 |